[HTML][HTML] The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses

WG Melsen, MCJ Bootsma, MM Rovers… - Clinical microbiology and …, 2014 - Elsevier
Variance between studies in a meta-analysis will exist. This heterogeneity may be of clinical,
methodological or statistical origin. The last of these is quantified by the I 2 -statistic. We …

Vancomycin-resistant enterococci: why are they here, and where do they come from?

MJM Bonten, R Willems, RA Weinstein - The Lancet infectious …, 2001 - thelancet.com
Vancomcyin-resistant enterococci (VRE) have emerged as nosocomial pathogens in the
past 10 years, causing epidemiological controversy. In the USA, colonisation with VRE is …

Identification of high-risk enterococcal clonal complexes: global dispersion and antibiotic resistance

HL Leavis, MJM Bonten, RJL Willems - Current opinion in microbiology, 2006 - Elsevier
Vancomycin-resistant Enterococcus faecium spread dramatically in hospital settings in the
USA in the 1990s and reached endemicity at the turn of the century. Similarly, rising …

[HTML][HTML] Decontamination of the digestive tract and oropharynx in ICU patients

A De Smet, J Kluytmans, BS Cooper… - … England Journal of …, 2009 - Mass Medical Soc
Background Selective digestive tract decontamination (SDD) and selective oropharyngeal
decontamination (SOD) are infection-prevention measures used in the treatment of some …

Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains

MA Leverstein‐van Hall, CM Dierikx… - Clinical Microbiology …, 2011 - Wiley Online Library
Clin Microbiol Infect 2011; 17: 873–880 Abstract Intestinal carriage of extended‐spectrum
beta‐lactamase (ESBL) ‐producing bacteria in food‐producing animals and contamination of …

Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report

Remap-Cap Investigators, AC Gordon, PR Mouncey… - Medrxiv, 2021 - medrxiv.org
Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …

[HTML][HTML] Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study

ME Kretzschmar, G Rozhnova, MCJ Bootsma… - The Lancet Public …, 2020 - thelancet.com
Background In countries with declining numbers of confirmed cases of COVID-19, lockdown
measures are gradually being lifted. However, even if most physical distancing measures …

[HTML][HTML] Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults

MJM Bonten, SM Huijts, M Bolkenbaas… - … England Journal of …, 2015 - Mass Medical Soc
Background Pneumococcal polysaccharide conjugate vaccines prevent pneumococcal
disease in infants, but their efficacy against pneumococcal community-acquired pneumonia in …

Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies

WG Melsen, MM Rovers, RHH Groenwold… - The Lancet infectious …, 2013 - thelancet.com
Background Estimating attributable mortality of ventilator-associated pneumonia has been
hampered by confounding factors, small sample sizes, and the difficulty of doing relevant …

Prevalence and outcomes of infection among patients in intensive care units in 2017

JL Vincent, Y Sakr, M Singer, I Martin-Loeches… - Jama, 2020 - jamanetwork.com
Importance Infection is frequent among patients in the intensive care unit (ICU). Contemporary
information about the types of infections, causative pathogens, and outcomes can aid the …